Oral Abstract Session 18: Inhaled Corticosteroids for Asthma

Tuesday, 6 December 2011: 12:45 - 14:15
Isla Mujeres (Cancún Center)
Chairpersons:   Diana Deleanu (Romania) and Stanley Szefler (US)
12:45 - 13:00
3192: A Post-Hoc Analysis of Asthma Control and Lung Function Following Treatment with Ciclesonide 80 µg HFA-MDI Twice Daily In Subjects with Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol | Eli Meltzer (US)
13:00 - 13:15
3193: The Particle Size of Mometasone Furoate 100 Mcg and 200 Mcg Dry Powder Formulations | Robert Berger (US)
13:15 - 13:30
3194: Clinical Efficacy of Once-Daily Mometasone Furoate in Children with Persistent Asthma Switched From Treatment with Fluticasone Propionate Ariel Teper (US)
13:30 - 13:45
3195: Inhaled Mometasone Furoate Improved Efficacy in Pediatric Asthma Patients Regardless of Previous Inhaled Corticosteroid Therapy: Pooled Data From the Ariel Teper (US)
13:45 - 14:00
3196: Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children | Said Arablin Oropeza (Mexico)
14:00 - 14:15
3197: Mometasone Furoate Vs Fluticasone Propionate in Mild Persistent Asthma: Retrospective Analysis of Asthma Control and Adherence Felicia Allen-Ramey (US)
See more of: Oral Abstract Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>